{"schema_version":"secwatch.filing_event.v1","accession":"0001736730-25-000043","form_type":"8-K","ticker":"CAMP","cik":"0001736730","company_name":"Camp4 Therapeutics Corp","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.517346+00:00","generated_at":"2026-05-19T08:40:54.474261+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"CAMP4 Therapeutics annual meeting elects four Class I directors, ratifies EY as auditor","bullets":["James Boylan elected with 15,802,709 votes for, 900,961 against, 6,002 abstain.","Amir Nashat, Andrew Schwab, and Douglas Williams each elected with >16 million votes for.","Ratification of Ernst & Young as auditor for FY2025: 17,900,199 for, 2,644 against, 6,002 abstain.","All proposals passed; meeting held June 11, 2025 as scheduled."],"urls":{"canonical":"https://secwatch.observer/filing/0001736730-25-000043","json":"https://secwatch.observer/filing/0001736730-25-000043.json","markdown":"https://secwatch.observer/filing/0001736730-25-000043.md","text":"https://secwatch.observer/filing/0001736730-25-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/0001736730-25-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/camp-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:40:54.474261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}